About
Pentixapharm Holding Ag — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 5 2026
Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism
Jan 7 2026
Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
Dec 3 2025
Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
Oct 23 2025
Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure
Oct 6 2025
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
Recent Videos

Pentixapharm Holding AG Shifts Focus to Advanced Clinical Development Programs
Jan 27, 2026

Biotech Industry Updates Roundup
Dec 29, 2025

E.ON, Renk & Pentixapharm: Das bewegt Covestro und Schaeffler
Dec 01, 2025

Eckert & Ziegler: Abspaltung beschlossen - Aktie vor dem Ausbruch?
Jun 27, 2024
Translate